Overview
Portfolio
More
Innvotec
London, United Kingdom
Focused on sustainable investments across various sectors.
Portfolio
17+
Employees
10+
Founded
1989
AUM
≈ $50.8M
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United Kingdom
Fund details
Funds
Anglo Scientific EIS Fund
Vintage 2017 • $50.8M
Sources
Innvotec
Focused on sustainable investments across various sectors.
Portfolio
17+
Employees
10+
Founded
1989
AUM
≈ $50.8M
Funds
Anglo Scientific EIS Fund · Vintage 2017 • $50.8M
Stages
No stages listed
Industries
No industries listedGeographic scope
United Kingdom
Sources
Showing 9 of 9 matched portfolio companies
The startup operates a medical technology platform that utilizes real-time biosensing to continuously monitor kidney function and metabolic health at the bedside. This technology enables clinicians to evaluate organ viability before transplantation and track patient recovery post-transplant, facilitating informed decisions regarding organ suitability and patient care.
Cognism provides B2B sales acceleration through a platform that delivers phone-verified mobile numbers and validated emails, enabling sales teams to connect with 87% of their target contacts. This technology reduces wasted dialing time and increases live conversations, allowing sales representatives to achieve their targets with significantly fewer calls.
Funding: $163.2M
Rough estimate of the amount of funding raised
Funding: $163.2M
Rough estimate of the amount of funding raised
Compare Ethics provides a compliance technology platform that automates the verification of sustainability claims, ensuring businesses meet evolving ESG regulations while significantly reducing compliance costs by up to 80%. The platform delivers rapid gap analysis and document verification, enabling companies to efficiently manage their green claims and mitigate legal and reputational risks.
Funding: $328.1K
Rough estimate of the amount of funding raised
Funding: $328.1K
Rough estimate of the amount of funding raised
The startup operates an impact platform that utilizes advanced sensor technology to detect and analyze the root causes of air and noise pollution. This enables organizations to implement targeted measures to protect employees and local communities from harmful environmental effects.
Fundment provides a platform that automates investment and account management processes for financial advisers, enabling streamlined client onboarding, rebalancing, and account opening. This technology enhances operational efficiency and personalization, allowing advisers to better serve their clients' unique financial needs.
Funding: $55.5M
Rough estimate of the amount of funding raised
Funding: $55.5M
Rough estimate of the amount of funding raised
SendSpend provides a digital e-payment system that enables users without bank accounts to make instant, secure transactions through a multi-currency eWallet and proprietary payment gateway. Users can deposit or withdraw cash at various agents nationwide, facilitating electronic payments for both consumers and businesses without the need for traditional banking infrastructure.
Tapoly provides an online platform for small businesses, freelancers, and corporates to obtain tailored business insurance coverage. The platform offers a range of policies including Professional Indemnity, Public Liability, and Cyber insurance, accessible through a fast quoting tool. This service helps professionals secure necessary risk protection to meet client demands and legal requirements.
Funding: $338.5K
Rough estimate of the amount of funding raised
Funding: $338.5K
Rough estimate of the amount of funding raised
This startup manufactures biodegradable packaging products using bio-resin and coated paper as sustainable alternatives to single-use plastics. Their solutions aim to significantly reduce plastic pollution by providing commercial clients with effective substitutes for millions of plastic straws.
Funding: $77.1M
Rough estimate of the amount of funding raised
Funding: $77.1M
Rough estimate of the amount of funding raised
The startup develops a drug-eluting intraocular lens technology that minimizes intraocular inflammation, infection, and opacification during cataract surgery. This lens enhances patient outcomes by eliminating the need for postoperative eye drops and reducing the likelihood of laser treatment.
Showing 8 of 8 unmatched portfolio companies